Syndromic agammaglobulinaemia (Q88427): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:39, 15 August 2026
This is a rare X-linked genetic disorder discovered in 1952 that affects the body's ability to fight infection. XLA is an X-linked disorder, and therefore is much more common in males. XLA patients do not generate mature B cells, which manifests as a complete lack of antibodies in their bloodstream.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1049161944 |
||
| English | Syndromic agammaglobulinaemia |
This is a rare X-linked genetic disorder discovered in 1952 that affects the body's ability to fight infection. XLA is an X-linked disorder, and therefore is much more common in males. XLA patients do not generate mature B cells, which manifests as a complete lack of antibodies in their bloodstream. |
Statements
CID11:ID_1049161944
0 references
dki-india-ID_1049161944
0 references
Concluído
0 references
13 August 2026
0 references
